Type 1 Diabetes News

Researchers have begun a clinical study of oral insulin to prevent or delay type 1 diabetes in at-risk people, the National Institutes of Health announced.

A new study has shown conclusively that a neuropeptide, melanin concentrating hormone (MCH), found in the brain and known for its role in increasing appetite in people, plays a role in the growth of insulin-producing beta cells and the secretion of insulin.

For the first time, scientists have discovered that cells passed from mother to child during pregnancy can differentiate into functioning islet beta cells that produce insulin in the child.

The American Academy of Ophthalmology wants Americans to know that even though diabetes is the leading cause of new cases of blindness, vision loss can be prevented if the disease is diagnosed and treated in time.

Investigators have successfully prevented the onset of type 1 diabetes in mice prone to developing the disease using an antibody against a receptor on the surface of immune T-cells. Findings have significant implications for the prevention of type 1 diabetes.

For patients with type 1 diabetes, obesity is an important risk factor for the development of diabetic kidney disease, reports a study in the January Journal of the American Society of Nephrology.

The cause of insulin-dependent, permanent, diabetes in newborn babies may be a deficiency in the enzyme Pancreatic Endoplasmic Reticulum Kinase (PERK) during a critical period of development before birth.

New data published in "Science" provide further support for a protocol to reverse type 1 diabetes in mice and new evidence that adult precursor cells from the spleen can contribute to the regeneration of beta cells.

Joslin study shows durability of insulin pump therapy for adolescents and identifies factors to help them overcome barriers to success.

Patients who have high blood sugar before undergoing surgery run an increased risk of developing blood clots, deep vein thrombosis and even pulmonary embolism after surgery.

Subsequent announcement provides two additional lot numbers that are included in the distribution of counterfeit products, along with descriptions of how to identify them.

Diabetic patients who use newer technologies such as insulin pumps and blood glucose monitoring devices are better able to manage their disease and adhere to treatment regimens, yet researchers have found that the newer methods are not being widely used because physicians may be reluctant to prescribe them, and even patients who are using them may not be deriving their full benefits.

The Edmonton Protocol for islet transplantation can safely and successfully promote long-term stabilization of blood sugar levels in "brittle" diabetes patients and in some cases, relieve them of the need for insulin injections altogether for at least two years.

In a six-year study of African Americans with type 1 diabetes, progression of diabetes-related eye disease was high and related to poor blood glucose control and high blood pressure.

Disetronic Medical Systems Inc. announced a voluntary nationwide recall of the Disetronic D-TRONplus Power Packs, that power the D-TRONplus Insulin Pump.

Researchers have found that the acute loss of a protein called menin can cause the proliferation of pancreatic islet cells, which secrete insulin to regulate blood sugar. Discovery has implications for treating Type 1 diabetes.